A Study of Postoperative Analgesia Using Dexmedetomidine as an Adjuvant to Bupivacaine in Ultrasound-Guided Suprainguinal Fascia Iliaca Block in Adults Undergoing Total Hip Arthroplasty Under Spinal Anesthesia.

To Evaluate the effect of dexmedetomidine as an adjuvant to bupivacaine in ultrasound guided supra inguinal fascia iliaca block for post operative analgesia in total hip arthroplasty surgery under spinal anesthesia - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/111749

Enrollment

Registered

2026-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M160- Bilateral primary osteoarthritis of hip Health Condition 2: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: BUPIVACAINE AND BUPIVICAINE WITH DEXMEDETOMIDINE: 1. ROUTE OF ADMINISTRATION: REGIONAL 2. GRP A - USG GUIDE SUPRAINGUINAL-FIC BLOCK 29ML 0.25% BUPIVACAINE + 1 ML N. GRP B - USG GUIDED S

Eligibility

Inclusion criteria

Inclusion criteria: ASA GRADE 1 AND 2

Exclusion criteria

Exclusion criteria: ASA GRADE 3 AND 4

Design outcomes

Primary

Measure	Time frame
Pulse Systolic Blood Pressure Diastolic Blood Pressure Spo2Timepoint: 2 hours 4 hours 6 hours 8 hours 12 hours 18 hours 24 hours	—

Secondary

Measure	Time frame
Duration of Analgesia.Timepoint: 2 hour 4 hour 6 hour 8 hour 12 hour 18 hour 24 hour	—

Countries

India

Contacts

Public ContactDr Asmita Chaudhary

GCS HOSPITAL AHEMEDABAD

asmivip@yahoo.co.in9879006601

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026